- Home
- CDIO
as of 09-15-2026 3:06pm EST
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 6.1M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 32.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.13 | EPS Growth: | -1096.77 |
| 52 Week Low/High: | $0.97 - $7.91 | Next Earning Date: | 05-13-2026 |
| Revenue: | $14,825 | Revenue Growth: | -57.51% |
| Revenue Growth (this year): | 171906.75% | Revenue Growth (next year): | N/A |
| P/E Ratio: | -1.80 | Index: | N/A |
| Free Cash Flow: | -5914150.0 | FCF Growth: | N/A |
Compare CDIO vs Leading Stocks
See how CDIO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CDIO Cardio Diagnostics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.